Hohimer Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hohimer Wealth Management's BMY Position: Q3 2026 in Review
Hohimer Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2026, buying an estimated $18.3K and bringing the position to 6,603 shares worth $412K. The position accounts for 0.04% of the portfolio, ranked #236.
Hohimer Wealth Management first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $4.94M in Q2 2021. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Hohimer Wealth Management held 6,603 shares of Bristol-Myers Squibb worth $412K as of Q3 2026.
- Hohimer Wealth Management bought 289 Bristol-Myers Squibb shares in Q3 2026, an estimated $18.3K.
- Bristol-Myers Squibb made up 0.04% of Hohimer Wealth Management's portfolio in Q3 2026, its #236 holding.
- Hohimer Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
- Hohimer Wealth Management's Bristol-Myers Squibb position peaked at $4.94M in Q2 2021.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Hohimer Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.